An Open Label, Non-comparative, Multicentre Study to Evaluate the Efficacy and Tolerability of Pregabalin in Peripheral Neuropathic Pain.
Phase of Trial: Phase III
Latest Information Update: 22 Apr 2011
At a glance
- Drugs Pregabalin (Primary)
- Indications Neuropathic pain
- Focus Therapeutic Use
- Sponsors Pfizer
- 02 Apr 2008 New trial record.